Director for Clinical Affairs, Digestive Diseases Div., Cedars-Sinai Med. Ctr. Professor, Medicine, University of California Los Angeles David Geffen SOM
Gastroenterology
Dr. Andrew F. Ippoliti, MD
|
|
Give Review
Doctor Andrew F. Ippoliti, MD works in the field of Gastroenterology. He went to Tulane University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Andrew Ippoliti is also published. He has 66 publications published. The lastest publication: "Detection of a circulating gastric secretagogue in plasma extracts from normogastrinemic patients with acid hypersecretion.' He is registered with Medicare.
Publications
- Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulc...
- Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis.
- Long-term outcomes of thalidomide in refractory Crohn's Disease.
- Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel Disease patients.
- Assessing health status in inflammatory bowel Disease using a novel single-item numeric rating scale.
- Multidimensional Prognostic Risk Assessment Identifies Association Between IL12B Variation and Surgery in Crohn's Disease.
- Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's Disease?
- Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's Disease.
- A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel Disease.
- Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in Duodenal ulcer and Zollinger-Ellison syndrome patients.
- Evidence that gastrin 34 is preferentially released from the human duodenum.
- Endocrine effects of acute and chronic cimetidine administration.
- Objective evaluation of symptomatic alkaline Reflux after antrectomy.
- Recurrent Ulcer after successful treatment with cimetidine or antacid.
- Esophageal motility abnormalities in cirrhotic patients before and after endoscopic variceal treatment.
- The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in Duodenal ulcer patients.
- Detection of a circulating Gastric secretagogue in plasma extracts from normogastrinemic patients with acid hypersecretion.
- Perfusion of the proximal small intestine with peptone stimulates Gastric acid secretion in man.
- Effect of one-month treatment with cimetidine on Gastric secretion and serum gastrin and pepsinogen levels.
- Effect of gastrin heptadecapeptide (G17) on oEsophageal contractions in patients with diffuse oEsophageal spasm.
- Esophageal motility in progressive Systemic sclerosis (PSS). Comparison of cine-radiographic and manometric evaluation.
- Cimetidine versus intensive antacid therapy for Duodenal ulcer: a multicenter trial.
- Esophagitis in scleroderma. Prevalence and risk factors.
- The effect of nicotine on the delay of Gastric emptying.
- Cyclosporine in Systemic sclerosis. Results of a forty-eight-week open safety study in ten patients.
- Esophageal biopsy.
- Two doses of omeprazole versus placebo in symptomatic erosive Esophagitis: the U.S. Multicenter Study.
- The diagnosis of Barrett's Esophagus: goblets, goblets, goblets.
- Intrahepatic cholesterol stones: a rationale for dissolution therapy.
- The prevalence of colonic neoplasia in patients with Barrett's Esophagus: prospective assessment in patients 50-80 years old.
- Effective and safe endoscopic reversal of nondysplastic Barrett's Esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.
- Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel Disease of unclassified type (IBDU).
- Inflammation of the gastro-oesophageal junction (carditis) in patients with symptomatic gastro-oesophageal reflux Disease: a prospective study.
- The economic impact of the diagnosis of dysplasia in Barrett's Esophagus.
- Linkage of Crohn's Disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation.
- IL23R haplotypes provide a large population attributable risk for Crohn's Disease.
- Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in Ulcerative colitis patients influence pouchitis development after ileal ...
- Family history and serology predict Crohn's Disease after ileal pouch-anal anastomosis for ulcerative colitis.
- A metaproteomic approach to study human-microbial ecoSystems at the mucosal luminal interface.
- Host-microbe relationships in inflammatory bowel Disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface.
- Variants in ZNF365 isoform D are associated with Crohn's Disease.
- Genetic predictors of medically refractory Ulcerative colitis.
- Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's Disease.
- Capsule endoscopy in patients with Crohn's Disease: diagnostic yield and safety.
- Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel Disease.
- A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel Disease-unclassified and indeterminate colitis.
- Esophageal perforation from a metal screw and plate.
- New clinical method for distinguishing D-IBS from other gastroIntestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.
- Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study.
- High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females.
- Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.
- Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with Ulcerative colitis?
- A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis.
- Predicting a change in diagnosis from ulcerative colitis to Crohn's Disease: a nested, case-control study.
- Genome-wide association study identifies new susceptibility loci for Crohn Disease and implicates autophagy in Disease pathogenesis.
- Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's Disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy.
- Anti-flagellin (CBir1) phenotypic and genetic Crohn's Disease associations.
- NOD2 variants and antibody response to microbial antigens in Crohn's Disease patients and their unaffected relatives.
- Antibodies to I2 predict clinical response to fecal diversion in Crohn's Disease.
- Patients with inflammatory bowel Disease are at risk for vaccine-preventable illnesses.
- Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's Disease.
- Elevated platelet count before ileal pouch-anal anastomosis for Ulcerative colitis is associated with the development of chronic pouchitis.
- Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett''s Esophagus.
- Safety and efficacy of adalimumab (D2E7) in Crohn's Disease patients with an attenuated response to infliximab.
- A pilot study of adalimumab in infliximab-allergic patients.
Schools
Tulane University School Of Medicine
DC General Hospital
Georgetown University Hospital
Wadsworth Va Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
VA Greater Los Angeles Healthcare System -
Georgetown University Hospital -
Tulane University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1881621308 | |
| NPPES Provider LastName | IPPOLITI | |
| NPPES Provider FirstName | ANDREW | |
| NPPES Provider ZIPCode | 900481865 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 407.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 28.0 | |
| Percent Opioid Claims | 6.88 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1881621308 |
| Last Name Of The Provider | IPPOLITI |
| First Name Of The Provider | ANDREW |
| View All |
Similar Doctors
|
Dr. Joel D. Feinstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Brelian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marvin Derezin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maurice Elihu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Said Rahban, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marianne Fahmy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick H. Takahashi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard S. Schecter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Horgan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil J. Sevy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert H. Wintroub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Anton, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Donald C. Gerety, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David D. Kim, MD |
|
|
Gati A. Goel |